Healthtech Investors & VC Firms in China

120 firms in this list, with a median first check of $1M. 6 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
LYZZ Capital 5 people	Shanghai	CN	Seed–Series A	—	+ Add to CRM
Redpoint Ace Ventures 5 people	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
Scientia Ventures 5 people	New York	US	Series A–Series B	—	+ Add to CRM
Tai Partners 5 people	Shanghai	CN	Seed–Series B	—	+ Add to CRM
Wuxi Healthcare Ventures Management Us Llc 5 people	Grand Cayman	US	Seed–Late Stage	—	+ Add to CRM
Zero2IPO 5 people	Beijing	CN	Seed–Late Stage	—	+ Add to CRM
Hotung Investment Holdings Ltd. 2 people	Taipei	TW	Series A–Late Stage	$300K – $1.5M	+ Add to CRM
OWW Capital Partners Pte. Ltd. 2 people	—	SG	Seed–Late Stage	$500K – $10M	+ Add to CRM
Gaorong Capital 4 people	Beijing	CN	Seed–Series B	—	+ Add to CRM
French Partners 1 person	Paris	FR	Seed–Series B	$1.1M – $5.4M	+ Add to CRM
Japan Asia Investment 1 person	Tokyo	JP	Seed–Late Stage	$1M – $10M	+ Add to CRM
South China Venture Capital 4 people	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
Tiantu Capital 4 people	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
Transcend Capital Partners 4 people	—	HK	Seed–Series A	—	+ Add to CRM
3H Health Investment 3 people	—	HK	Series A–Late Stage	—	+ Add to CRM
Ameba Capital 3 people	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
Brinc	Hong Kong	HK	Pre-Seed–Seed	$100K – $500K	+ Add to CRM
Hundreds Capital 3 people	Beijing	CN	Seed–Late Stage	—	+ Add to CRM
Lang Sheng Investment Group Co. Ltd. 3 people	Shanghai	CN	Series A–Series B	—	+ Add to CRM
Rockley Group 3 people	Oxford	GB	Growth	—	+ Add to CRM
Taihill Venture 3 people	Cambridge	US	Pre-Seed–Series A	—	+ Add to CRM
Alibaba Entrepreneurs Fund 2 people	Hong Kong	HK	Seed–Late Stage	—	+ Add to CRM
BioTrack Capital 2 people	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
Cathay Health 2 people	Paris	FR	Seed–Late Stage	—	+ Add to CRM